Summary by Moomoo AI
Howard G. Welgus, a Director at Arcutis Biotherapeutics, Inc., is set to sell 10,000 shares of common stock on 09/03/2024, with an aggregate market value of $107,695. The shares were originally acquired on 06/04/2018 through a stock option exercise from Arcutis Biotherapeutics Inc, and were paid for in cash. This planned sale follows a three-month period where Welgus sold a total of 30,000 shares, grossing $271,936. The notice for the upcoming sale was filed on the same date as the planned sale, with the instruction for this transaction given on 03/05/2024.
